Chromatin immunoprecipitation analysis indicated that the levels of H3K9ac were reduced, and levels of H3K9me were increased around the methylated -132 site in BRCA1-mutated breast cancer (Fig. 4A). The gene discussed is BRCA1; the disease is breast carcinoma.